SCHEMBL861172

SCHEMBL861172

C#Cc1ccc2c(c1)OCO2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.48
ALDH1A1 P00352 3/20 0.44
HSD17B10 Q99714 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
MAPK1 P28482 1/20 0.42
ABCG2 Q9UNQ0 1/20 0.42
TAAR1 Q96RJ0 1/20 0.41
ATM Q13315 1/20 0.41
CMA1 P23946 1/20 0.41
MAOB P27338 3/20 0.41
MIF P14174 1/20 0.41
MAPT P10636 2/20 0.40
GAA P10253 1/20 0.40
SLC6A4 P31645 1/20 0.40
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
POLB P06746 1/20 0.40
RAB9A P51151 1/20 0.40
KMT2A Q03164 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6018971 1.00 CYP3A4 (0.48) CYP3A4ALDH1A1HSD17B10TDP1MAPK1
SCHEMBL31399387 0.82 MAPT (0.53) MAPTGAAPOLBKMT2ASMN1; SMN2
SCHEMBL17365209 0.82 MAPT (0.53) MAPTGAAPOLBKMT2ASMN1; SMN2
SCHEMBL5048104 0.79 ACACB (0.45)
SCHEMBL10745644 0.78 MIF (0.49) CYP3A4ALDH1A1HSD17B10TDP1MAPK1
SCHEMBL30300332 0.78 MAPT (0.51) CYP3A4ALDH1A1HSD17B10TDP1MAPT
SCHEMBL140150 0.78 MAPT (0.51) CYP3A4ALDH1A1HSD17B10TDP1MAPT
SCHEMBL9432285 0.78 CYP3A4 (0.48) CYP3A4ALDH1A1HSD17B10TDP1MAPK1
SCHEMBL97197 0.78 NPC1 (0.48) CYP3A4ALDH1A1HSD17B10TDP1MAPK1
SCHEMBL4656696 0.75 CYP3A4 (0.45) CYP3A4ALDH1A1HSD17B10TDP1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114507121-A Preparation method and product of alpha-alkenyl-alpha, alpha-difluoroaryl ketone compound 南京工业大学 2022-05-17 CN claimed
CN-109704926-B Anticancer active molecular skeleton 1, 4-eneyne compound and preparation method and application thereof 南京工业大学 2022-02-08 CN claimed
US-20250136580-A1 INDOLINONE DERIVATIVES AS INHIBITORS OF MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2025-05-01 US disclosed
WO-2025076285-A1 COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME DELPHIA THERAPEUTICS, INC. (US) 2025-04-10 WO disclosed
CN-114507121-B Preparation method and product of alpha-alkenyl-alpha, alpha-difluoro aryl ketone compound 南京工业大学 2023-05-26 CN disclosed
CN-114507121-A Preparation method and product of alpha-alkenyl-alpha, alpha-difluoroaryl ketone compound 南京工业大学 2022-05-17 CN disclosed
CN-109704926-B Anticancer active molecular skeleton 1, 4-eneyne compound and preparation method and application thereof 南京工业大学 2022-02-08 CN disclosed
US-20210317107-A1 INDOLINONE DERIVATIVES AS INHIBITORS OF MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2021-10-14 US disclosed
US-20210317107-A1 INDOLINONE DERIVATIVES AS INHIBITORS OF MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2021-10-14 US disclosed
US-10981896-B2 Indolinone derivatives as inhibitors of maternal embryonic leucine zipper kinase BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2021-04-20 US disclosed
US-10981896-B2 Indolinone derivatives as inhibitors of maternal embryonic leucine zipper kinase BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2021-04-20 US disclosed
US-4760087-A 5-lipoxygenase inhibitor GRUENENTHAL GMBH (DE) 1988-07-26 US disclosed
EP-0202529-A2 Phenol derivatives, pharmaceutical compositions containing them and processes for the preparation of these compounds and pharmaceutical compositions Grünenthal GmbH (DE) 1986-11-26 EP disclosed
US-4515768-A STABILIZER AGAINST THERMAL DECOMPOSITION AIRWICK INDUSTRIES, INC. (US) 1985-05-07 US disclosed
EP-0036385-B1 INSECTICIDAL VAPOUR-EMITTING COMPOSITIONS ON THE BASIS OF PYRETHRINOIDS Airwick AG (CH) 1984-05-02 EP disclosed
US-4439415-A PYRETHRINOID AND ABSORPTIVE SUBSTRATE AIRWICK INDUSTRIES, INC. (US) 1984-03-27 US disclosed
EP-0036385-A2 Insecticidal vapour-emitting compositions on the basis of pyrethrinoids Airwick AG (CH) 1981-09-23 EP disclosed
US-4209517-A α-Ethylenic alcohols and ketones, their preparation, and their use as medicaments UNICLER (FR) 1980-06-24 US disclosed
US-4037353-A Device for emitting vapors of active substance AIRWICK INDUSTRIES, INC. (US) 1977-07-26 US disclosed
US-4037352-A PYRETHRINOIDS AIRWICK INDUSTRIES, INC. (US) 1977-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317107-A1 INDOLINONE DERIVATIVES AS INHIBITORS OF MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE MELK, HIPK1, HIPK3 CYP3A4 4805/4885ALDH1A1 3459/4885HSD17B10 2643/4885
US-10981896-B2 Indolinone derivatives as inhibitors of maternal embryonic leucine zipper kinase MELK, HIPK1, HIPK3 CYP3A4 4783/4885ALDH1A1 2911/4885HSD17B10 2489/4885
US-20250136580-A1 INDOLINONE DERIVATIVES AS INHIBITORS OF MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE MELK, HIPK1, HIPK3 CYP3A4 4805/4885ALDH1A1 3459/4885HSD17B10 2643/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.